Preferences for Herceptin SC or IV administration (PrefHer)
Trial Coordinator: Kathryn Monson
Lead Researchers: Sue Catt
PrefHer is an industry-funded, multi-centre study, examining patient preference between two methods of administering an important breast cancer drug. This crossover study, being conducted across 12 countries, will use pre- and post-treatment questionnaires to determine which method of administration patients prefer. The study will also evaluate the experiences and satisfaction of health care professionals with the two methods, and explore the factors influencing patient preference.